Helix Biopharma Stock Price, News & Analysis (TSE:HBP)

C$0.94 +0.04 (+4.44 %)
(As of 02/22/2018 04:00 PM ET)
Previous CloseC$0.90
Today's RangeC$0.94 - C$0.94
52-Week RangeC$0.70 - C$1.39
Volume500 shs
Average Volume8,163 shs
Market CapitalizationC$95.65 million
P/E Ratio-9.40
Dividend YieldN/A
Beta0.25

About Helix Biopharma (TSE:HBP)

Helix BioPharma Corp. is an immuno-oncology company, which specializes in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its technologies. The Company's product development initiatives are focused primarily on technologies that modulate the tumor microenvironment. The Company's technology platform, DOS47 yielded approximately two drug product candidates, L-DOS47 and vDOS47. L-DOS47 is an antibody protein conjugate where the urease component enzymatically converts naturally occurring urea to ammonia. L-DOS47 is under clinical study for the treatment of non-small cell lung cancer (NSCLC). L-DOS47 has completed preclinical testing and manufacturing development, following which, regulatory approvals are obtained in Poland and the United States to conduct Phase I/II and Phase I clinical studies. V-DOS47 is an antibody DOS47 conjugate that targets the vascular endothelial growth factor 2 receptor (VEGFR2).

Receive HBP News and Ratings via Email

Sign-up to receive the latest news and ratings for HBP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorHealthcare
SymbolTSE:HBP
CUSIPN/A
Phone+1-416-9253232

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-9.4
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($0.10)
Net IncomeN/A
Net MarginsN/A
Return on Equity-874.75%
Return on Assets-294.09%

Miscellaneous

EmployeesN/A
Outstanding Shares100,062,000

Helix Biopharma (TSE:HBP) Frequently Asked Questions

What is Helix Biopharma's stock symbol?

Helix Biopharma trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HBP."

How were Helix Biopharma's earnings last quarter?

Helix Biopharma Corp. (TSE:HBP) issued its earnings results on Wednesday, December, 13th. The biopharmaceutical company reported ($0.02) EPS for the quarter. View Helix Biopharma's Earnings History.

When will Helix Biopharma make its next earnings announcement?

Helix Biopharma is scheduled to release their next quarterly earnings announcement on Friday, March, 16th 2018. View Earnings Estimates for Helix Biopharma.

Who are some of Helix Biopharma's key competitors?

Who are Helix Biopharma's key executives?

Helix Biopharma's management team includes the folowing people:

  • Sven Rohmann M.D., Ph.D., Chairman of the Board (Age 52)
  • Heman Chao Ph.D., Chief Executive Officer, Chief Scientific Officer (Age 54)
  • Photios Michalargias, Chief Financial Officer (Age 50)
  • George J. Anders, Director
  • Sylwester Eugeniusz Cacek, Director
  • Theordore Witek Jr., Director
  • Slawomir Majewski M.D., Independent Director (Age 57)
  • Marek Jan Orlowski, Independent Director (Age 47)

How do I buy Helix Biopharma stock?

Shares of Helix Biopharma and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Helix Biopharma's stock price today?

One share of Helix Biopharma stock can currently be purchased for approximately C$0.94.

How big of a company is Helix Biopharma?

Helix Biopharma has a market capitalization of C$95.65 million.

How can I contact Helix Biopharma?

Helix Biopharma's mailing address is 21 St Clair Ave E Suite 1100, TORONTO, ON M4T 1L9, Canada. The biopharmaceutical company can be reached via phone at +1-416-9253232.


MarketBeat Community Rating for Helix Biopharma (HBP)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about Helix Biopharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Helix Biopharma (TSE:HBP) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Helix Biopharma (TSE:HBP) Earnings History and Estimates Chart

Earnings by Quarter for Helix Biopharma (TSE:HBP)

Helix Biopharma (TSE HBP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/16/2018        
12/13/2017Q1 2018C($0.02)ViewN/AView Earnings Details
10/27/2017Q4 2017C($0.01)ViewN/AView Earnings Details
6/13/2017Q3 2017C($0.03)ViewN/AView Earnings Details
3/17/2017Q2 2017C($0.03)ViewN/AView Earnings Details
12/13/2016Q1 2017C($0.04)C$0.03 millionViewN/AView Earnings Details
10/31/2016Q4 2016C($0.03)ViewN/AView Earnings Details
6/14/2016Q3 2016C($0.02)ViewN/AView Earnings Details
3/16/2016Q2 2016C($0.03)ViewN/AView Earnings Details
12/11/2015Q1 2016C($0.03)ViewN/AView Earnings Details
10/29/2015Q4 2015C($0.02)ViewN/AView Earnings Details
6/15/2015Q3 2015C($0.03)ViewN/AView Earnings Details
3/10/2015Q2 2015C($0.03)ViewN/AView Earnings Details
12/15/2014Q1 2015C($0.03)ViewN/AView Earnings Details
10/23/2014Q4 2014C($0.02)ViewN/AView Earnings Details
6/12/2014Q3 2014C($0.03)ViewN/AView Earnings Details
3/14/2014Q2 2014C($0.04)ViewN/AView Earnings Details
12/13/2013Q1 2014C($0.03)ViewN/AView Earnings Details
10/29/2013Q4 2013C($0.03)ViewN/AView Earnings Details
6/18/2013Q3 2013C($0.03)ViewN/AView Earnings Details
3/11/2013Q2 2013C($0.03)ViewN/AView Earnings Details
12/12/2012Q1 2013C($0.03)ViewN/AView Earnings Details
10/25/2012Q4 2012C($0.02)ViewN/AView Earnings Details
6/14/2012Q3 2012C($0.04)ViewN/AView Earnings Details
3/16/2012Q2 2012C($0.14)ViewN/AView Earnings Details
1/13/2012Q1 2012C($0.05)ViewN/AView Earnings Details
10/31/2011Q4 2011C($0.03)ViewN/AView Earnings Details
6/7/2011Q3 2011C($0.05)ViewN/AView Earnings Details
3/4/2011Q2 2011C($0.04)ViewN/AView Earnings Details
12/10/2010Q1 2011C($0.06)ViewN/AView Earnings Details
10/29/2010Q4 2010C($0.05)ViewN/AView Earnings Details
6/11/2010Q3 2010C($0.07)ViewN/AView Earnings Details
3/10/2010Q2 2010C($0.06)ViewN/AView Earnings Details
12/9/2009Q1 2010C($0.06)C($0.06)ViewN/AView Earnings Details
10/29/2009Q4 2009C($0.07)C($0.06)ViewN/AView Earnings Details
6/15/2009Q3 2009C($0.08)ViewN/AView Earnings Details
3/16/2009Q2 2009C($0.08)ViewN/AView Earnings Details
12/11/2008Q1 2009C($0.05)ViewN/AView Earnings Details
6/11/2008Q3 2008C($0.03)ViewN/AView Earnings Details
3/10/2008Q2 2008C($0.04)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Helix Biopharma (TSE:HBP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Helix Biopharma (TSE:HBP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Helix Biopharma (TSE HBP) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Helix Biopharma (TSE:HBP)

Helix Biopharma (TSE HBP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/26/2017Marek Jan OrlowskiDirectorSell5,000C$0.90C$4,500.00
4/17/2015Steve DemasInsiderSell3,000C$1.80C$5,400.00
4/16/2015Steve DemasInsiderSell2,000C$1.80C$3,600.00
(Data available from 1/1/2013 forward)

Headlines

Helix Biopharma (TSE HBP) News Headlines

Source:
DateHeadline
Helix Biopharma Corp. (HBP) Set to Announce Earnings on MondayHelix Biopharma Corp. (HBP) Set to Announce Earnings on Monday
www.americanbankingnews.com - October 23 at 5:16 AM

SEC Filings

Helix Biopharma (TSE:HBP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Helix Biopharma (TSE HBP) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.